Mason Carrico

Stock Analyst at Stephens & Co.

(0)
# 4595
Out of 5,329 analysts
78
Total ratings
21.67%
Success rate
-18.04%
Average return
19 Stocks
Name Action PT Current % Upside Ratings Updated
VCYT Veracyte
Reiterates: Overweight
45 45
29.7 51.52% 6 Mar 26, 2025
OCX OncoCyte
Reiterates: Equal-Weight
4 4
3.12 28.21% 5 Mar 26, 2025
GH Guardant Health
Reiterates: Overweight
55 55
48.88 12.52% 5 Mar 26, 2025
AKYA Akoya Biosciences
Downgrades: Equal-Weight
4 2
1.2 50% 6 Mar 25, 2025
CTKB Cytek Biosciences
Reiterates: Overweight
6 6
3.71 61.73% 2 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
17 17
18.41 -7.66% 2 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
156 156
76.54 103.81% 7 Mar 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
52 52
31.12 67.1% 2 Mar 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
40 40
15.06 165.6% 9 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
3 3
1.1 127.27% 4 Feb 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
84 84
57.27 46.67% 3 Feb 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
14 13
n/a n/a 1 Jan 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
20 20
7.13 180.5% 4 Jan 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
65 65
38.09 70.65% 1 Jan 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
41 41
19.31 112.33% 7 Jan 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
30 30
8.1 270.37% 5 Oct 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
125 125
151.63 -17.56% 4 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
19 19
7.29 160.63% 1 Jul 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
2 2
n/a n/a 4 Apr 19, 2024